| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dd98ad4ee076841fec541542f952f58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_515ebf3a9161fe8ba77cb8918441dbb6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate |
2006-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35a492137bfa916e26f2036ee1b151f5 |
| publicationDate |
2006-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006124324-A1 |
| titleOfInvention |
Therapeutic compositions and methods |
| abstract |
The present invention includes compositions and methods that provide protection in a patient suffering from an eye disease such as age-related macular degeneration. In certain embodiments, the compositions of the present invention are administered during degeneration, and the composition includes an effective amount of an agent that increases choroidal blood flow. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008075104-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114276251-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114276251-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9975910-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11612633-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3801465-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2804300-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015012210-A1 |
| priorityDate |
2005-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |